Timing and Scope Clause Samples

Timing and Scope. The EIM Entity Scheduling Coordinator must provide any such forecasts by 10:00 a.m. for the next 7 days.
View SourceView Similar (4)
Timing and Scope. (a) No later than June 1, 2017 the OPA will initiate a mid-term review (the “Mid-Term Review”) of: (i) the 7 TWh target specified in the Ministry of Energy’s direction referred to in Recital C to this Agreement; (ii) allocation of budgets and distribution companies CDM targets; (iii) lessons learned on cost recovery and performance incentive mechanisms; and (iv) CDM contribution to regional planning. (b) As part of the Mid-Term Review, the OPA will review: (i) the Eligible Expenses to date as compared to the CDM Plan Budget; (ii) the LDC’s progress to the CDM Plan Target based on verified and reported electricity savings for 2015 to 2017; and (iii) the achievable potential study conducted under section 2.6. (c) As part of the Mid-Term Review, where the CDM Plan identifies a target gap, the LDC will resubmit the CDM Plan in accordance with the CDM Plan Submission and Review Criteria Rules (and other Rules, as may be applicable) to indicate how its full CDM Plan Target could be achieved.
View SourceView Similar (2)
Timing and Scope. Within 24 hours of Institution’s first awareness of an SAE/NS-AE, or immediately if the SAE is fatal or life-threatening, Institution will notify Pfizer by email of any SAE/NS-AEs for which reporting hereunder is required. SAEs/NS- AEs that are subject to these reporting requirements are those that occur in: (i) Study subjects who are assigned to receive the Pfizer Product; or (ii) individuals otherwise exposed to the Pfizer Product. onemocnění nebo úraz, trvalé poškození tělesné funkce nebo trvalé poškození těla nebo vyžaduje lékařský nebo chirurgický zákrok, aby k trvalému poškození tělesné funkce nebo trvalému poškození těla nedošlo. Pojmem „trvalý“ se rozumí nevratné zhoršení funkce nebo poškození části těla nebo tělesné funkce, s vyjma zanedbatelného zhoršení funkce nebo poškození. „Událostí podléhající hlášení“ se rozumí jakákoli Závažná nežádoucí ▇▇▇▇▇▇▇, Incident zdravotnického prostředku či Závažný incident zdravotnického prostředku, jednotlivě nebo společně. Pokud je Přípravek společnosti Pfizer zdravotnickým prostředkem nebo obsahuje zdravotnický prostředek, vykládají se odkazy na Závažnou nežádoucí příhodu obsažené v této Smlouvě tak, že zahrnují odkazy na pojem „Událost podléhající hlášení“. Požadavky na hlášení. Doplňující informace o požadavcích uvedených v této Smlouvě a podrobné informace o hlášení Závažných, resp. Nezávažných nežádoucích příhod společnosti Pfizer (včetně příslušných formulářů pro hlášení a návodů k vyplnění) byly poskytnuty Hlavnímu zkoušejícímu a jsou k dispozici v online grantovém systému společnosti Pfizer. Instituce zajistí, aby tyto doplňující a podrobné informace byly poskytnuty všem Pracovníkům, kteří se podílejí na Studii a kteří podávají hlášení o Závažných nežádoucích příhodách. 1. Další požadavky na prospektivní studie na výzkumných pracovištích v rámci EU: Nezávažné nežádoucí příhody, které jsou v Protokolu označeny jako události, které podléhají hlášení, jsou společnosti Pfizer povinna hlásit pouze výzkumná pracoviště v Evropské unii (EU).
View Source
Timing and Scope. (a) No later than June 1, 2017 the IESO will initiate a mid-term review (the “Mid-Term Review”) of: (i) the 7 TWh target specified in the Ministry of Energy’s direction referred to in Recital C to this Agreement; (ii) allocation of budgets and distribution companies CDM targets; (iii) lessons learned on cost recovery and performance incentive mechanisms; and (iv) CDM contribution to regional planning. (b) As part of the Mid-Term Review, the IESO will review: (i) the Eligible Expenses to date as compared to the CDM Plan Budget; (ii) the LDC’s progress to the CDM Plan Target based on verified and reported electricity savings for 2015 to 2017; and (iii) the achievable potential study conducted under section 2.6. (c) As part of the Mid-Term Review, where the CDM Plan identifies a target gap, the LDC will resubmit the CDM Plan in accordance with the CDM Plan Submission and Review Criteria Rules (and other Rules, as may be applicable) to indicate how its full CDM Plan Target could be achieved. (d) Following the conclusion of the Mid-Term Review, where the CDM Plan contains any unassigned targets, the LDC will resubmit the CDM Plan in accordance with the CDM Plan Submission and Review Criteria Rules (and other Rules, as may be applicable) to assign all previously unassigned targets to one or more Programs.
View Source
Timing and Scope. This Agreement relates by time and scope to the current semester.
View Source

Related to Timing and Scope

  • Purpose and Scope The purpose of these standard contractual clauses is to ensure compliance with the requirements of Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulation)1 for the transfer of personal data to a third country.

  • Definitions and Scope 1.1 Employees shall have the right to present grievances in accordance with the procedures prescribed in this Article. 1.2 For purposes of this Agreement, a grievance is a dispute concerning the interpretation or application of the terms or provisions of this Agreement. It is intended that this shall not mean administrative matters under the Retirement System and the Group Health Insurance Program.

  • Background Screening and Security All Contractor employees, Subcontractors and agents of the Contractor performing work under the Contract must comply with all background screening and security requirements of the Department, as detailed below.

  • Object and Scope of the Agreement The competent authorities of the Contracting Parties shall provide assistance through exchange of information that is foreseeably relevant to the administration and enforcement of the domestic laws of the Contracting Parties concerning taxes covered by this Agreement. Such information shall include information that is foreseeably relevant to the determination, assessment and collection of such taxes, the recovery and enforcement of tax claims, or the investigation or prosecution of tax matters. Information shall be exchanged in accordance with the provisions of this Agreement and shall be treated as confidential in the manner provided in Article 8. The rights and safeguards secured to persons by the laws or administrative practice of the requested Party remain applicable to the extent that they do not unduly prevent or delay effective exchange of information.

  • PURPOSE AND SCOPE OF AGREEMENT 1.01 The purpose of this Agreement is to maintain harmonious and mutually beneficial relationships between the Employer, the Union and the employees and to set forth herein certain terms and conditions of employment upon which agreement has been reached through collective bargaining. 1.02 The parties to this Agreement share a desire to improve the quality of the Canadian Food Inspection Agency and to promote the well-being and increased efficiency of its employees to the end that the people of Canada will be well and efficiently served. Accordingly, the parties are determined to establish, within the framework provided by law, an effective working relationship at all levels of the Agency in which members of the bargaining units are employed.